Later, when the subjects were divided according to the presence of NASH, an increase in OLFM2 relative expression in the NASH group was observed in comparison with the non-NASH group, as shown in Figure 1B. However, regarding OLFM4, we did not report significant differences between groups (Figure 1C,D). Here, OLFM2 is linked to metabolic dysfunction-associated steatohepatitis.